BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26900348)

  • 1. Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy.
    Xu JH; Hu SL; Shen GD; Shen G
    Cancer Cell Int; 2016; 16():13. PubMed ID: 26900348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor genes associated with drug resistance in ovarian cancer (review).
    Yin F; Liu X; Li D; Wang Q; Zhang W; Li L
    Oncol Rep; 2013 Jul; 30(1):3-10. PubMed ID: 23660957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Profiling of Paclitaxel Treated Cells Identifies a Novel Mechanism of Drug Resistance Mediated by PDCD4.
    Xu H; Dephoure N; Sun H; Zhang H; Fan F; Liu J; Ning X; Dai S; Liu B; Gao M; Fu S; Gygi SP; Zhou C
    J Proteome Res; 2015 Jun; 14(6):2480-91. PubMed ID: 25928036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function.
    Gao L; Wu ZX; Assaraf YG; Chen ZS; Wang L
    Drug Resist Updat; 2021 Jul; 57():100770. PubMed ID: 34175687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenes and tumor suppressor genes: comparative genomics and network perspectives.
    Zhu K; Liu Q; Zhou Y; Tao C; Zhao Z; Sun J; Xu H
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S8. PubMed ID: 26099335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
    Park SH; Seong MA; Lee HY
    Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study.
    Zhao M; Zhao Z
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):532. PubMed ID: 27556634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network.
    Zhou K; Liu M; Cao Y
    Front Mol Biosci; 2017; 4():46. PubMed ID: 28736730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSGene: a web resource for tumor suppressor genes.
    Zhao M; Sun J; Zhao Z
    Nucleic Acids Res; 2013 Jan; 41(Database issue):D970-6. PubMed ID: 23066107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
    Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
    Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes.
    Zhao M; Kim P; Mitra R; Zhao J; Zhao Z
    Nucleic Acids Res; 2016 Jan; 44(D1):D1023-31. PubMed ID: 26590405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease association of human tumor suppressor genes.
    Das AB
    Mol Genet Genomics; 2019 Aug; 294(4):931-940. PubMed ID: 30945018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.
    Tao L; Wu YQ; Zhang SP
    Neoplasma; 2019 Sep; 66(5):746-755. PubMed ID: 31169019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways.
    Karthikeyan S; Hoti SL; Nazeer Y; Hegde HV
    Oncotarget; 2016 Jul; 7(27):42353-42373. PubMed ID: 27304668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ING tumor suppressor genes: status in human tumors.
    Guérillon C; Bigot N; Pedeux R
    Cancer Lett; 2014 Apr; 345(1):1-16. PubMed ID: 24333729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
    Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.
    Zhang W; Cai J; Chen S; Zheng X; Hu S; Dong W; Lu J; Xing J; Dong Y
    Mol Med Rep; 2015 Jul; 12(1):1506-14. PubMed ID: 25760096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predicting clinical chemo-sensitivity of primary ovarian cancer using adenosine triphosphate-tumor chemosensitivity assay combined with detection of drug resistance genes].
    Zhao D; Zhang W; Li XG; Wang XB; Zhang LF; Li M; Li YF; Tian HM; Song PP; Liu J; Chang QY; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):193-8. PubMed ID: 21575453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone.
    Sugimura M; Sagae S; Ishioka S; Nishioka Y; Tsukada K; Kudo R
    Oncology; 2004; 66(1):53-61. PubMed ID: 15031599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation.
    Aldonza MB; Hong JY; Alinsug MV; Song J; Lee SK
    Oncotarget; 2016 Jun; 7(23):34395-419. PubMed ID: 27284014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.